MIG Capital: BioNTech Has Transformed Global View Of German Biotech 'But We Don’t Walk On Water’
After BioNTech, German VC Leader Looks To Next Challenge
MIG Capital’s Matthias Kromayer looks back at the huge success of its long-term backing of BioNTech and discusses the group’s next big life sciences investments, but warns that realism and hard work are needed to achieve another breakthrough.
